Carina Syring
VP, External Manufacturing
Bristol Myers Squibb
18 June 2026
7.00 – 8.00 CET
DELEGATE REGISTRATION AND NETWORKING BREAKFAST
8.00 – 8.10 CET
Chair's opening remarks
External Manufacturing
External Quality
Manda Pasarkar
Director, Global Regulatory Affairs, CMC
Sanofi
8.10 – 8.40 CET
Keynote
Maria Rigotti
Global Quality Officer
Chiesi
Transforming Pharmaceutical Operations to Drive Efficiency, Agility, and Long-Term Supply Resilience
- Modernizing operational models to reduce complexity and improve end-to-end execution across internal and external networks
- Building agile manufacturing and supply structures that respond faster to demand shifts and capacity constraints
- Embedding operational excellence principles to drive sustainable efficiency without compromising quality or compliance
- Strengthening cross-functional collaboration between supply, quality, technical operations, and external partners
- Improving decision-making speed through better governance, data visibility, and escalation pathways
8.40 – 9.10 CET
PLENARY
Dominik Loitz, Ph.D.
SVP and Head, External Manufacturing
Bayer
Building the Next Generation of Contract Manufacturing Networks in Healthcare
- Strengthening strategic partnerships across global contract manufacturing networks
- Balancing capacity, flexibility, and risk in evolving healthcare supply chains
- Enhancing collaboration between sponsors, CMOs, and critical supply partners
- Leveraging digitalization and data visibility to improve network performance
- Building more resilient and scalable manufacturing ecosystems for future demand
9.15 - 9.45 CET
Workshops
Room 1
Brian Daleiden
VP, Corporate Marketing and Demand Generation
TraceLink
Pierre-Jacques Evrard
Senior Solution Consultant
TraceLink
Agentic Orchestration in Action: From Digitalization to Intelligent Execution
- Driving cross-enterprise digitalization of business transactions to improve efficiency and reduce manual complexity
- Enabling no-code orchestration across commercial, manufacturing, quality, and logistics processes
- Leveraging AI agents to interpret real-time data, automate workflows, detect exceptions, and support decision-making
- Mapping the agentic value journey - from digitalization to orchestration to intelligent, autonomous execution
Room 2
Dejan Lamešić, Ph.D
Director, Product Development
Catalent
Maximizing Value Through Strategic CDMO Partnership
- Highlighting Catalent’s approach to seamless collaboration from early development through commercial supply execution
- Leveraging integrated drug delivery technologies to overcome formulation and bioavailability challenges
- Streamlining technology transfers to support predictable scale-up across dosage forms
- Driving resilient clinical and commercial supply through optimized packaging and distribution
- Enhancing operational oversight across a global CDMO network to mitigate supply risk and protect timelines
9.50 – 11.10 CET
Refreshments, Networking and Pre-Arranged 1-2-1 Meetings
11.15 – 11.45 CET
STREAMS
EXTERNAL MANUFACTURING
Linda Intoft Gauffin
Senior Director, Manufacturing Technical Operations
Calliditas Therapeutics
Maximizing Supplier Relationship Performance: Strengthening Collaboration and Long-Term Value
- Strengthening supplier relationship management to improve performance and operational alignment
- Building collaborative partnerships that drive long-term value across external manufacturing networks
- Identifying and addressing performance gaps through structured governance and communication
- Aligning quality, supply, and business objectives to improve responsiveness and reliability
- Maximizing the return on supplier relationships through transparency, accountability, and continuous improvement
EXTERNAL QUALITY
Alba Fernández Font
Director, cGMP, External Partners
GSK
Rolv Vereertbrugghen
Senior Manager, External Partners
GSK
Strengthening CDMO Governance in the R&D Space to Improve Oversight, Execution, and Accountability
- Defining governance frameworks to manage cross-functional CDMO relationships
- Aligning internal roles and responsibilities for vendor oversight
- Tracking project progress through structured review boards
- Balancing central and regional control in decision-making.
- Driving accountability with transparent escalation mechanisms
- Standardizing communication and documentation protocols across teams
11.50 - 12.20 CET
Plenary
Shaun Crofts
Executive Director, External Quality
Gilead Sciences
Failure is Predictable: Why Outsourced Manufacturing Breaks – and How to Prevent It
- Understanding how natural sponsor-CMO tensions can influence decision-making
- Defining fit-for-purpose oversight and when sponsors should step back
- Balancing efficiency and cost discipline without compromising compliance
- Building learning systems that prioritize insight over reassurance
- Strengthening quality culture as a key predictor of outsourcing success
12.25 - 13.25 CET
Lunch & Learn Roundtable Discussions
Benefit from additional learning by joining a moderated roundtable discussion on pressing issues in the industry. Registration is required, and attendance is limited. Choose from:
Golo Heckmann
Head, API and Chemical Process Development, Animal Health
Boehringer Ingelheim
From External Development to Commercial Supply – Building Resilient GMP‑Compliant API Networks
Joana Gaspar
Associate Director, CMC Compliance Strategy, Integrations
Grünenthal
From Compliance to Product Excellence: Strategic Evolution of CMC
Marty Hughes
Executive Director, CMC
Immuneering
Building Adaptive Operations to Withstand Geopolitical Shifts and Regulatory Disruptions
Katherine Barton
Senior Director, CMC Global Regulatory Affairs
Fulcrum Therapeutics
Bridging CMC Innovation and Regulatory Compliance for Global Manufacturing Agility
Joseph Vu
Executive Director, Regulatory Affairs, Strategy and CMC
Taiho Oncology
Enhancing CMC Quality Assurance to Strengthen Global External Manufacturing Networks
Marina Palumbo
Senior Director, Cluster Head, External Supply Operations, Quality
Pfizer
Strengthening External Supply Quality Operations to Protect Supply and Compliance Globally
Emma Newton
Head, Product QA
Astellas Pharma Europe
Partnering for Quality: Aligning CMO Excellence with Pharma QA Expectations
Salomon Engels
Head, External Manufacturing
Par Health (formerly Mallinckrodt-Endo)
Defining the KPIs That Improve Vendor Performance and Operational Reliability
13.30 - 14.15 CET
Panel Discussion
Kristina Kölerud
Senior Director, External Manufacturing
LEO Pharma
Anna Löfgren
SVP and Head, Quality Assurance
Hansa Biopharma
Liesbeth Foesters
VP and Head, External and Clinical Supply Quality
UCBAgnes Roque-Cera
Director, Quality Control
Gilead SciencesBeverly Smith
Senior Director, Technical Capabilities
Bristol Myers Squibb
Monica Aragoneses Palomo
Head, Quality Cluster E&A Operations, Global Quality, Global Operations
Stada Arzneimittel AG
Women In Leadership
- What changes have you seen genuinely help women progress into senior leadership roles?
- What key experiences or leadership lessons have shaped your own career journey?
- How can organizations better support women in areas such as visibility, confidence, communication styles, and access to networks?
- How do cultural backgrounds and workplace expectations influence leadership styles and career progression?
- Women are often highly collaborative and supportive leaders - how can leaders balance supporting others while also advocating for themselves?
- What practical actions can organizations take to build more diverse and future-ready leadership teams?
14.20 - 14.50 CET
Plenary
Tina Self
SVP and Global Head, Biologics Manufacturing
Bayer
Maximizing Capabilities and Capacities Through Niche CDMO Offerings
- Managing timing and capacity challenges across pipeline development and transitions into clinical and launch manufacturing
- Exploring Bayer’s approach to filling gaps in clinical and launch manufacturing schedules to maximize resources
- Designing BioPartnering Solutions offerings to support niche customer and manufacturing needs
- Leveraging targeted “insourcing” opportunities to strengthen internal capabilities and support broader partnering engagements
14.55 - 15.40 CET
Panel Discussion
Joseph Vu
Executive Director, Regulatory Affairs, Strategy and CMC
Taiho OncologyRoeland Vandebrouck
Senior Director and Head, External Supply Operations
Grünenthal Group
Catherine Seigneur
Senior Director, External Manufacturing Business Lead
UCBSalomon Engels
Head, External Manufacturing
Par Health (formerly Mallinckrodt-Endo)Carina Syring
VP, External Manufacturing
Bristol Myers SquibbGolo Heckmann
Head, API and Chemical Process Development, Animal Health
Boehringer Ingelheim
Optimizing CDMO Partnerships for Long-Term Success and Strategic Alignment
- Defining what differentiates a truly strategic CDMO partnership from a transactional relationship
- Balancing flexibility, speed, and control across commercial supply partnerships
- Evaluating the benefits of “one-stop shop” CDMOs versus specialized technical providers
- Governance models and communication structures for long-term CDMO collaborations
- Improving transparency, data exchange, and digital connectivity between sponsors and CDMOs
- Building long-term trust, innovation, and co-creation between sponsors and CDMOs
15.40 - 15.50 CET
Chair's Closing Remarks
External Manufacturing
Carina Syring
VP, External Manufacturing
Bristol Myers Squibb
External Quality
Manda Pasarkar
Director, Global Regulatory Affairs, CMC
Sanofi
Unlock Exclusive Summit Details
Exclusive summit content is reserved for qualified participants—request access today or enter your password.
